AI-Powered portable MRI could bring epilepsy diagnosis to millions who lack access

NCT ID NCT07717632

Ongoing Diagnosis Sponsor: University College, London Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study explores whether a low-cost, portable MRI machine enhanced with artificial intelligence can detect brain abnormalities in people with epilepsy as accurately as standard high-field MRI. About 30 adults with epilepsy who have already had a high-field MRI will also receive a low-field MRI scan. Researchers will compare the two scans to see how well the AI-enhanced low-field version identifies lesions, which could make epilepsy diagnosis more accessible in low- and middle-income countries.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Low-field MRI with AI image enhancement
What this could lead to: If successful, this could make brain imaging for epilepsy diagnosis more accessible and affordable in low-resource settings worldwide.
What could go wrong: This is a small early-stage study, and the AI-enhanced low-field MRI may not detect all abnormalities seen on standard MRI. Results may not generalize to all epilepsy types or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPILEPSY

Contacts and locations

Show contact details

Locations

UCL Queen Square Institute of Neurology

London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.